Grants and Contributions:
Title:
Analytics Development to Support Production of CAR-T Cell Therapy
Agreement Number:
1020634
Agreement Value:
$75,000.00
Agreement Date:
Jul 1, 2024 - Feb 28, 2025
Description:
Three CAR-T Analytics Platforms to Support Production:
1. Development & Optimization of Flow Cytometry Panels for CD19 CAR-T Immunophenotyping
2. Development of a qPCR method for CD19 CAR Gene Expression and Vector Copy Number (VCN)
3. Use of Synthetic Cell Mimics for Tech Transfer of Flow Cytometry Panels from Clients to AD/QC teams at OmniaBio
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 1M1
Reference Number:
172-2024-2025-Q2-1020634
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
777842949
Recipient Type:
For-profit organization
Recipient's Legal Name:
OmniaBio Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410